Abeona Therapeutics Inc. (LON:0H7R)
London
· Delayed Price · Currency is GBP · Price in USD 5.87
+0.04 (0.70%)
At close: Feb 21, 2025
Abeona Therapeutics Revenue
In the year 2023, Abeona Therapeutics had annual revenue of $3.50M USD with 147.52% growth.
Revenue
$3.50M
Revenue Growth
+147.52%
P/S Ratio
n/a
Revenue / Employee
$41.67K
Employees
84
Market Cap
198.76M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| Hikma Pharmaceuticals | 2.39B |
| ConvaTec Group | 1.74B |
| HUTCHMED (China) | 483.31M |
| Genus | 668.80M |
Abeona Therapeutics News
- 20 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics: Despite Some Competitive Pressure, This Looks Undervalued - Seeking Alpha
- 4 weeks ago - Insider Sell: Mark Alvino Sells 4,000 Shares of Abeona Therapeutics Inc (ABEO) - GuruFocus
- 7 weeks ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces Participation in November Investor Conferences - GlobeNewsWire
- 4 months ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire